CAS, a division of the American Chemical Society specializing in scientific information solutions, has launched a major expansion of the CAS SciFinder Discovery Platform into life sciences.   The enhanced platform includes over two million modified biosequences, 60 years of patent literature, and one of the largest collections of journal information including PubMed’s biomedical and life science data.   “The past decade has shown huge progress in biologic drug discovery. Research in oncology...